Trimetrexate in locally advanced or metastatic adenocarcinoma of the pancreas. A phase II study of the Northern California Oncology Group.
Carlson
R W
RW
Department of Medicine, Stanford University, CA 94305.
Doroshow
J H
JH
Odujinrin
O O
OO
Flam
M S
MS
Malec
M
M
Lamborn
K R
KR
D000230:Adenocarcinoma / Q000188:drug therapy*; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004341:Drug Evaluation; D015507:Drugs, Investigational / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010190:Pancreatic Neoplasms / Q000188:drug therapy*; D011799:Quinazolines / Q000009:adverse effects / Q000627:therapeutic use*; D016597:Trimetrexate
D000970:Antineoplastic Agents; D015507:Drugs, Investigational; D011799:Quinazolines; D016597:Trimetrexate